What is IMN ?
The Institute of Neurodegenerative Diseases (IMN) is a Joint Research Unit (UMR 5293) associating the University of Bordeaux and the CNRS. It was created in January 2011 under the direction of Erwan BEZARD. Geographically dispersed for a long time, it regrouped at the Center Broca Nouvelle-Aquitaine in 2017. Its creation represented a major advance in the structuring of neuroscience research in Bordeaux and it is now one of the 5 building blocks of the Bordeaux Neurocampus, the Department of Neurosciences at the University of Bordeaux. It is now made up of 11 fundamental and preclinical research teams and a clinical research team backed by the Bordeaux University Hospital.
IMN combines fundamental, preclinical and clinical research with the aim of:
- Develop new therapeutic approaches for neurodegenerative diseases by facilitating translational research from the laboratory to the patient bed.
- Increase its visibility and attractiveness in the field of translational neurosciences (Parkinson’s disease and atypical parkinsonian syndromes, Alzheimer’s disease, obsessive-compulsive disorders, etc.) and fundamental (planning, cognition, motor control, molecular substrates of transmission synaptic) by relying on the potential of its teams and the dynamics put in place since its creation.
Director of IMN: Thomas BORAUD
Deputy directors: Jérôme BAUFRETON & Wassilios MEISSNER